{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:38:23Z","timestamp":1789749503043,"version":"4.0.1"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,29]]},"DOI":"10.1093\/ibd\/izy174","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T11:55:48Z","timestamp":1526558148000},"page":"2510-2517","source":"Crossref","is-referenced-by-count":40,"title":["Pyoderma Gangrenosum: A Review for the Gastroenterologist"],"prefix":"10.1093","volume":"24","author":[{"given":"Isabella","family":"Plumptre","sequence":"first","affiliation":[{"name":"London North West University Healthcare NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Knabel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Tomecki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"key\n\t\t\t\t2018112902045856600_CIT0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MD.0b013e318187cc9c","article-title":"Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients","volume":"87","author":"Farhi","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0002","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0003","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/apt.12431","article-title":"Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy","volume":"38","author":"Agarwal","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0004","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jss.2016.06.045","article-title":"Pediatric pyoderma gangrenosum: is it just big wounds on little adults","volume":"206","author":"Soleimani","year":"2016","journal-title":"J Surg Res"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0005","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1365-2133.1997.20022083.x","article-title":"Pyoderma gangrenosum: a report of 44 cases with follow-up","volume":"137","author":"von den Driesch","year":"1997","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","article-title":"Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions","volume":"79","author":"Bennett","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0007","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/1346-8138.13937","article-title":"Pyoderma gangrenosum and underlying diseases in Japanese patients: a regional long-term study","volume":"44","author":"Inoue","year":"2017","journal-title":"J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0008","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","article-title":"Pyoderma gangrenosum","volume":"351","author":"Callen","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/bmj.333.7560.181","article-title":"Diagnosis and treatment of pyoderma gangrenosum","volume":"333","author":"Brooklyn","year":"2006","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0010","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0011","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0012","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0013","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0014","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1600-0560.2007.00744.x","article-title":"Expression of MMP-9, MMP-10 and TNF-alpha and lack of epithelial MMP-1 and MMP-26 characterize pyoderma gangrenosum","volume":"34","author":"Bister","year":"2007","journal-title":"J Cutan Pathol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2249.2010.04201.x","article-title":"Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases","volume":"162","author":"Marzano","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0016","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/eji.201141921","article-title":"The NLRP3\/ASC\/caspase-1 axis regulates IL-1\u03b2 processing in neutrophils","volume":"42","author":"Mankan","year":"2012","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0017","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2133.1982.tb11684.x","article-title":"Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosis","volume":"106","author":"Bentley-Phillips","year":"1982","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0018","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1523-1747.1998.00311.x","article-title":"Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum","volume":"111","author":"Adachi","year":"1998","journal-title":"J Invest Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0019","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/bjd.13493","article-title":"The genetics of pyoderma gangrenosum and implications for treatment: a systematic review","volume":"172","author":"DeFilippis","year":"2015","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.MIB.0000442011.60285.68","article-title":"Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients","volume":"20","author":"Weizman","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.crohns.2012.02.020","article-title":"TRAF3ip2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease","volume":"7","author":"Ciccacci","year":"2013","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0022","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","article-title":"Pyoderma gangrenosum: classification and management","volume":"34","author":"Powell","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0023","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2230.2003.01418.x","article-title":"Pustular pyoderma gangrenosum","volume":"28","author":"Shankar","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0024","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0020-7292(91)90823-N","article-title":"Vulvar pyoderma gangrenosum","volume":"35","author":"McCalmont","year":"1991","journal-title":"Int J Gynaecol Obstet"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/01443615.2017.1328590","article-title":"Skin diseases of the vulva: inflammatory, erosive-ulcerating and apocrine gland diseases, zinc and vitamin deficiency, vulvodynia and vestibulodynia","volume":"38","author":"Sand","year":"2018","journal-title":"J Obstet Gynaecol (Lahore)"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0026","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12105-017-0804-3","article-title":"Oral pyoderma gangrenosum: diagnosis, treatment and challenges: a systematic review","volume":"11","author":"Bissonnette","year":"2018","journal-title":"Head Neck Pathol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0027","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1067\/mjd.2000.104515","article-title":"Parastomal pyoderma gangrenosum: clinical features and management","volume":"42","author":"Lyon","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0028","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.284.12.1546","article-title":"Clinical features and treatment of peristomal pyoderma gangrenosum","volume":"284","author":"Hughes","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0029","first-page":"196","article-title":"Factors associated with stoma quality of life among stoma patients","volume":"1","author":"Liao","year":"2014","journal-title":"Int J Nurs Sci"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bjps.2014.12.036","article-title":"A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management stratDegy","volume":"68","author":"Zuo","year":"2015","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0031","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jaad.2017.09.040","article-title":"Risk of developing pyoderma gangrenosum after procedures in patients with a known history of pyoderma gangrenosum\u2014a retrospective analysis","volume":"78","author":"Xia","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0032","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaad.2015.06.054","article-title":"Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014","volume":"73","author":"Tolkachjov","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0033","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/gut.4.4.299","article-title":"The course and prognosis of ulcerative colitis","volume":"4","author":"Edwards","year":"1963","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0034","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/ijd.13591","article-title":"Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients","volume":"56","author":"Vacas","year":"2017","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/CCID.S61202","article-title":"Pyoderma gangrenosum: challenges and solutions","volume":"8","author":"Gameiro","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0036","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"A Delphi consensus of international experts for diagnostic criteria of ulcerative pyoderma gangrenosum","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0037","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa013383","article-title":"Skin ulcers misdiagnosed as pyoderma gangrenosum","volume":"347","author":"Weenig","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0038","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.otsr.2017.01.009","article-title":"Pyoderma gangrenosum or necrotising fasciitis? Diagnostic and therapeutic wanderings","volume":"103","author":"Vaysse-Vic","year":"2017","journal-title":"Orthop Traumatol Surg Res"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0039","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/SAP.0000000000001070","article-title":"Postsurgical pyoderma gangrenosum versus necrotizing fasciitis: can we spot the difference","volume":"78","author":"Touil","year":"2017","journal-title":"Ann Plast Surg"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0040","first-page":"691","article-title":"Sporotrichosis masquerading as pyoderma gangrenosum","volume":"122","author":"Lima","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0041","first-page":"3218","article-title":"Comparison of pyoderma gangrenosum and hypertensive ischemic leg ulcer Martorell in a Swiss cohort","volume":"12","author":"Kolios","year":"2017","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0042","first-page":"967","article-title":"Pain and pain management in dermatology","volume":"13","author":"Beiteke","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0043","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/01.ASW.0000526605.34372.9e","article-title":"Pyoderma gangrenosum: a critical appraisal","volume":"30","author":"Shavit","year":"2017","journal-title":"Adv Skin Wound Care"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0044","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.jaad.2015.05.010","article-title":"Peristomal pyoderma gangrenosum (PG): a simple hydrocolloid dressing technique to promote wound healing","volume":"73","author":"Rodenbeck","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0045","doi-asserted-by":"crossref","first-page":"e1072","DOI":"10.1097\/GOX.0000000000001072","article-title":"Successful treatment of pyoderma gangrenosum after augmentation mastopexy using vacuum therapy","volume":"4","author":"Soncini","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0046","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1590\/S0365-05962011000600022","article-title":"Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum","volume":"86","author":"Vieira","year":"2011","journal-title":"An Bras Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0047","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.ASW.0000397898.56121.3f","article-title":"A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents","volume":"24","author":"Duchini","year":"2011","journal-title":"Adv Skin Wound Care"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0048","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"60","author":"Mowat","year":"2011","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0049","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jpainsymman.2017.06.005","article-title":"Topical medical cannabis: a new treatment for wound pain-three cases of pyoderma gangrenosum","volume":"54","author":"Maida","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.12968\/jowc.2013.22.2.68","article-title":"Pyoderma gangrenosum: guideline for wound practitioners","volume":"22","author":"Ratnagobal","year":"2013","journal-title":"J Wound Care"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0051","first-page":"34","article-title":"Treatment options for pyoderma gangrenosum","volume":"15","author":"Quist","year":"2017","journal-title":"J Dtsch Dermatol Ges"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0052","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaad.2016.06.016","article-title":"Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: a prospective cohort study","volume":"75","author":"Thomas","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0053","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/095466301750163518","article-title":"Topical tacrolimus in the management of peristomal pyoderma gangrenosum","volume":"12","author":"Lyon","year":"2001","journal-title":"J Dermatolog Treat"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0054","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/09546630310019364","article-title":"Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream","volume":"15","author":"Patel","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0055","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/archderm.134.9.1071","article-title":"Nicotine for pyoderma gangrenosum","volume":"134","author":"Wolf","year":"1998","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0056","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/120347541201600503","article-title":"Successful treatment of localized pyoderma gangrenosum with topical pimecrolimus","volume":"16","author":"Cecchi","year":"2012","journal-title":"J Cutan Med Surg"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0057","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1468-3083.2007.02280.x","article-title":"Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%","volume":"22","author":"Bellini","year":"2008","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0058","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/dth.12318","article-title":"Use of becaplermin for nondiabetic ulcers: pyoderma gangrenosum and calciphylaxis","volume":"29","author":"Twu","year":"2016","journal-title":"Dermatol Ther"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0059","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2230.1992.tb00254.x","article-title":"Pyoderma gangrenosum\u2013response to topical nitrogen mustard","volume":"17","author":"Tsele","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1684\/ejd.2013.2147","article-title":"Treatment of pyoderma gangrenosum with topical factor XIII","volume":"23","author":"Hoetzenecker","year":"2013","journal-title":"Eur J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0061","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1742-481X.2010.00725.x","article-title":"Two percent topical phenytoin sodium solution in treating pyoderma gangrenosum: a cohort study","volume":"7","author":"Fonseka","year":"2010","journal-title":"Int Wound J"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0062","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0063","doi-asserted-by":"crossref","first-page":"h2958","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial","volume":"350","author":"Ormerod","year":"2015","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0064"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/03007995.2016.1267616","article-title":"Assessment of corticosteroid-related quality of care measures for ulcerative colitis and Crohn\u2019s disease in the United States: a claims data analysis","volume":"33","author":"Rubin","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0066","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0067","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ijd.13584","article-title":"Pediatric pyoderma gangrenosum: a systematic review and update","volume":"56","author":"Kechichian","year":"2017","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0068","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/bjd.15850","article-title":"Intravenous immunoglobulin as adjunct therapy for refractory pyoderma gangrenosum: systematic review of cases and case series","volume":"178","author":"Song","year":"2018","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0069","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-2133.2007.08217.x","article-title":"Treatment of pyoderma gangrenosum with intravenous immunoglobulin","volume":"157","author":"Cummins","year":"2007","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0070","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1365-2133.2007.08433.x","article-title":"Intravenous immunoglobulin for pyoderma gangrenosum","volume":"158","author":"Kreuter","year":"2008","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0071","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000481432","article-title":"Clinical disease patterns in a regional swiss cohort of 34 pyoderma gangrenosum patients","volume":"233","author":"Kolios","year":"2017","journal-title":"Dermatology"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0072","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/RHU.0000000000000511","article-title":"Successful treatment of autoimmune disease-associated pyoderma gangrenosum with the IL-1 receptor antagonist anakinra: a case series of 3 patients","volume":"23","author":"Beynon","year":"2017","journal-title":"J Clin Rheumatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0073","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0074","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2340\/00015555-2008","article-title":"Effective strategies for the management of pyoderma gangrenosum: a comprehensive review","volume":"95","author":"Patel","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0075","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archdermatol.2011.168","article-title":"Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab","volume":"147","author":"Guenova","year":"2011","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0076","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ajg.2012.42","article-title":"Ustekinumab for peristomal pyoderma gangrenosum","volume":"107","author":"Fahmy","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0077","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1089\/wound.2011.0339","article-title":"Effective strategies for the management of pyoderma gangrenosum","volume":"1","author":"Goodarzi","year":"2012","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0078","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2015.09.009","article-title":"Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and split thickness skin grafting under adequate immunosuppression is a valuable treatment option: case series of 15 patients","volume":"74","author":"Pichler","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0079","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.rdc.2007.07.016","article-title":"Pyoderma gangrenosum: an update","volume":"33","author":"Callen","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0080","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jaad.2016.07.049","article-title":"Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum","volume":"75","author":"Wilkes","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0081","doi-asserted-by":"crossref","first-page":"521","DOI":"10.12968\/jowc.2009.18.12.45610","article-title":"Pyoderma gangrenosum: from misdiagnosis to recognition, a personal perspective","volume":"18","author":"Hemp","year":"2009","journal-title":"J Wound Care"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0082","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/1534734617710980","article-title":"Pyoderma gangrenosum: a current problem as much as an unknown one","volume":"16","author":"Vallini","year":"2017","journal-title":"Int J Low Extrem Wounds"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0083","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09546630410031909","article-title":"Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features","volume":"15","author":"Vidal","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"key\n\t\t\t\t2018112902045856600_CIT0084"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/24\/12\/2510\/26864021\/izy174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T21:00:33Z","timestamp":1720299633000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/24\/12\/2510\/4998841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":84,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,5,17]]},"published-print":{"date-parts":[[2018,11,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izy174","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,5,17]]}}}